PubMed HealthSearch

PubMed · 2249607

The ExacTech blood glucose testing system.

Abstract

The ExacTech system, a new device for home measurement of blood glucose was tested in the laboratory, in the out-patient clinic, and by diabetic patients. The system is based on an electrochemical principle, and consists of specially impregnated strips and a small, pencil-shaped meter. (1) Six meters were tested in the laboratory at blood glucose concentrations of 4, 10 and 20 mmol/l. Low coefficients of variation were found at 10 and 20 mmol/l, but those at 4 mmol/l were rather high (approximately 10%). Analysis of variances showed no difference in the between and the within variation of the meters. (2) The blood glucose concentrations of 50 consecutive out-patients were determined by the ExacTech system and a standard laboratory method. Correlation analysis showed an r value of 0.95 (P less than 0.001). (3) The results obtained by 13 patients repeating the correlation experiment were in agreement with the second part of the study. The ExacTech system is very simple to operate by the patients, and can be recommended for home monitoring of blood glucose.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K O Kyvik, J Traulsen, B Reinholdt, A Frøland. The ExacTech blood glucose testing system.. https://doi.org/10.1016/0168-8227(90)90085-8

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[A case of insulinoma with frequent hypoglycemic attacks not showing evident hyperinsulinemia].

Confirmation of inappropriate hyperinsulinemia is an indispensable requisite for the diagnosis of insulinoma. We report here a case of insulinoma without evident hyperinsulinemia at an early stage. The patient, a 49-year-old woman, had been admitted to our hospital for the evaluation of frequent hypoglycemic attacks. At that time, plasma immunoreactive insulin (IRI) after an overnight fast ranged from 7 to 16 microU/ml. The ratio of IRI/fasting blood sugar (FBS) (Fajans index; normal range, below 0.3) was always between 0.13 and 0.28 even at hypoglycemic states. In addition, because computed tomography and arteriography of the abdomen failed to settle the diagnosis of insulinoma, the patient was discharged and followed up at our outpatient clinic for 2 years. She was admitted to our hospital at 51 years of age for the re-evaluation of hypoglycemic attacks. Laboratory examinations revealed high fasting plasma levels of IRI ranging from 20 to 29 microU/ml. Fajans index also increased to 0.47-0.89. Celiac arteriography was able to confirm the existence of insulinoma. We suggest that insulinoma should be considered in the presence of unexplained hypoglycemic attacks even when there is no evident hyperinsulinemia.

Blood Glucose

[Glycemic index of foods].

The glycaemic index of foods describes the hyperglycaemic effect of isolated foods. It is measured by the ratio of the area under the glycaemic curve observed after ingestion of a 50 gram carbohydrate dose of the tested food to the area observed after ingestion of the same amount of a reference food (white bread). The glycaemic index classification provides an approach of the diabetic diet based on the glucose response to foods. Widely accepted when applied to isolated foods, its clinical utility during mixed meals remains discussed. The improvement of the average metabolic control which can be expected from its use is modest. However, its major interest could be observed during snacks and meals in order to control precisely post-prandial glucose variations, in association with blood glucose self-monitoring. As it allows high sweet taste-low-glycaemic index-carbohydrate foods to be consumed, it could significantly improve the quality of life of diabetic patients.

Blood Glucose